Stay updated on Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial
Sign up to get notified when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.

Latest updates to the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page
- ChecktodayChange DetectedA new history entry for Revision: v3.3.4 was added after Revision: v3.3.3.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a new revision note: Revision: v3.3.3. The footer/links were updated by removing 'HHS Vulnerability Disclosure' and the older 'Revision: v3.3.2'.SummaryDifference0.2%

- Check50 days agoChange DetectedA new version entry (v3.3.2) was added to the Study Record Versions, and the old entry (v3.2.0) was removed.SummaryDifference0.1%

- Check57 days agoChange DetectedA site-wide notice about a lapse in government funding is now displayed, indicating that the information on the site may not be up to date and transactions may not be processed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check71 days agoChange DetectedVersion 8 (2024-10-09) adds new sections such as Document Section, Participant Flow, Baseline Characteristics, Outcome Measures (Results), Adverse Events, and Limitations and Caveats, and updates multiple areas including Study Identification, Study Status, Study Description, Arms and Interventions, and Contacts/Locations.SummaryDifference0.1%

- Check100 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference11%

Stay in the know with updates to Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.